ConductScience.org, home

Paper41979751

Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy.

Ayyıldız Sevim H and 5 others. Discov Oncol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy. Papers, record 41979751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41979751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy.
PubMed
Journal
Discov Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ayyıldız Sevim HHatice
2Atak MMehmetcan
3Altundağ Derin ZZeynep
4Çelik SSelahattin
5Gültekin İBİsmail Burak
6Yazılıtaş DDoğan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135127741Total Parenteral Nutrition Treatment Improves the Nutrition Status of Gynecological Cancer Patients by Improving Serum Albumin Level.Front Med (Lausanne)2021https://conductscience.org/library/papers/35127741PubMed
239450552Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review).Int J Mol Med2025https://conductscience.org/library/papers/39450552PubMed
340282892Mean Platelet Volume-to-Albumin Ratio as a Predictor of Mortality in Patients with Febrile Neutropenia: An Observational Study.Medicina (Kaunas)2025https://conductscience.org/library/papers/40282892PubMed
423704196
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
Ann Oncol2013https://conductscience.org/library/papers/23704196PubMed
517063500Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.Cancer2006https://conductscience.org/library/papers/17063500PubMed
626418235Prognostic and predictive immune gene signatures in breast cancer.Curr Opin Oncol2015https://conductscience.org/library/papers/26418235PubMed
736869395Blood biomarkers as potential malnutrition screening alternatives among adult patients with cancer on treatment in oncology unit of jimma tertiary hospital: A cross-sectional analysis.BMC Nutr2023https://conductscience.org/library/papers/36869395PubMed
824529560Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.Lancet2014https://conductscience.org/library/papers/24529560PubMed
928956830Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?Cancers (Basel)2017https://conductscience.org/library/papers/28956830PubMed
1031695497Platelet Volume Is Reduced In Metastasing Breast Cancer: Blood Profiles Reveal Significant Shifts.Cancer Manag Res2019https://conductscience.org/library/papers/31695497PubMed
1131159248Nutritional Laboratory Markers in Malnutrition.J Clin Med2019https://conductscience.org/library/papers/31159248PubMed
1220690807Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US.Cancer Invest2010https://conductscience.org/library/papers/20690807PubMed
1339826475Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges.ESMO Open2025https://conductscience.org/library/papers/39826475PubMed
1439036381The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy.J Natl Cancer Cent2024https://conductscience.org/library/papers/39036381PubMed
1529677116Human Cancer and Platelet Interaction, a Potential Therapeutic Target.Int J Mol Sci2018https://conductscience.org/library/papers/29677116PubMed
1630288759Hypoalbuminemia: Pathogenesis and Clinical Significance.JPEN J Parenter Enteral Nutr2019https://conductscience.org/library/papers/30288759PubMed
1732010567
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
Transl Lung Cancer Res2019https://conductscience.org/library/papers/32010567PubMed
1830305116Role of platelets and platelet receptors in cancer metastasis.J Hematol Oncol2018https://conductscience.org/library/papers/30305116PubMed
1931148950Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions.Mediators Inflamm2019https://conductscience.org/library/papers/31148950PubMed
2030912405Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical CancerAsian Pac J Cancer Prev2019https://conductscience.org/library/papers/30912405PubMed

See all 30 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41979751

GET https://conductscience.org/api/papers/v1/41979751/references?page=2